You are here
Aligned Nanofibrillar Scaffold Activated with HGF-mmRNA in Combination with Minced Muscle Graft for Treating Volumetric Muscle Loss (VML) Injury
Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH19C0021
Agency Tracking Number: H2-0402
Amount:
$996,609.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
DHP14-009
Solicitation Number:
14.1
Timeline
Solicitation Year:
2014
Award Year:
2019
Award Start Date (Proposal Award Date):
2019-02-07
Award End Date (Contract End Date):
2021-07-06
Small Business Information
32930 Alvarado-Niles Rd.
Suite 350
Union City, CA
94587
United States
DUNS:
023369802
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Michael Paukshto
Title: CTO, Co-Founder
Phone: (650) 492-1440
Email: mpaukshto@fibralignbio.com
Title: CTO, Co-Founder
Phone: (650) 492-1440
Email: mpaukshto@fibralignbio.com
Business Contact
Name: Greg King
Phone: (415) 902-4721
Email: gking@fibralignbio.com
Phone: (415) 902-4721
Email: gking@fibralignbio.com
Research Institution
N/A
Abstract
To address the scarcity of effective treatments for volumetric muscle loss injuries, we propose a novel aligned multilumen nanofibrillar collagen scaffold loaded with Hepatocyte Growth Factor (HGF) modified messenger RNA (mmRNA) to direct functional muscl
* Information listed above is at the time of submission. *
